Psychosocial Evaluation Matters
Mary Amanda Dew, Andrea F. DiMartini – 22 January 2021
Leveraging the Coronavirus Disease 2019 Pandemic: Is It Time to Consider Incorporating Mobile Applications Into Standard Clinical Management of the Liver Transplantation Patient?
Alison Faust, Jonathan G. Stine – 22 January 2021
Liver Transplantation for Langerhans Cell Histiocytosis: A US Population‐Based Analysis and Systematic Review of the Literature
Ioannis A. Ziogas, Christos D. Kakos, W. Kelly Wu, Martin I. Montenovo, Lea K. Matsuoka, Sara Zarnegar‐Lumley, Sophoclis P. Alexopoulos – 22 January 2021 – Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder. Liver involvement is seen in 10.1% to 19.8% of patients with LCH and can lead to secondary sclerosing cholangitis requiring liver transplantation (LT). We describe the characteristics and outcomes of patients undergoing LT for LCH.
The Difference a Decade Makes
Gregory J. Gores, Mark A. McNiven, Lewis R. Roberts – 21 January 2021
Masthead
21 January 2021
Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells
Claudia De Pasquale, Stefania Campana, Chiara Barberi, Giacomo Sidoti Migliore, Daniela Oliveri, Marika Lanza, Cristina Musolino, Giovanni Raimondo, Soldano Ferrone, Teresa Pollicino, Guido Ferlazzo – 21 January 2021
Cover Image
21 January 2021
Table of contents
21 January 2021
LiverLearning®: 2021 Webinar: To Stop or Not to Stop: The Practice of Finite Nucleos(t)ide Analog Therapy
This one-hour webinar will summarize the data that supports the finite strategy of nucleos(t)ide analog (NA) therapy in patients with chronic hepatitis B. Further discussion on how the presenter practices the strategy. In the second half of the webinar, the presenter will present data that argues against the rationale of a finite NA therapy. The presenter will elaborate on why stopping NA before loss of HBsAg cannot be recommended.
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members
Mairene Coto‐Llerena, Nadia Tosti, Stephanie Taha‐Mehlitz, Venkatesh Kancherla, Viola Paradiso, John Gallon, Gaia Bianco, Andrea Garofoli, Souvik Ghosh, Fengyuan Tang, Caner Ercan, Gerhard M. Christofori, Matthias S. Matter, Raoul A. Droeser, Mihaela Zavolan, Savas D. Soysal, Markus Flüe, Otto Kollmar, Luigi M. Terracciano, Charlotte K. Y.